Using Artificial Intelligence to Better Predict and Develop Biomarkers.

Sam A Michelhaugh1, James L Januzzi2

  • 1Georgetown University School of Medicine, Washington, DC, USA.

Summary

Technological advancements, including omics and artificial intelligence (AI), are revolutionizing heart failure (HF) biomarker discovery. These tools enhance risk identification, patient monitoring, and treatment strategies for improved HF care.